These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6380378)

  • 1. [The eradication of measles by general vaccination is beneficial and feasible].
    Rey M
    Ann Pediatr (Paris); 1984 Jun; 31(6):483-7. PubMed ID: 6380378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of vaccination policies. The case of measles].
    Lafarge H; Levy E; Rey M
    Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eradication of measles. Strategies in the Autonomous Community of Catalonia].
    Salleras Sanmartí L; Domínguez García A; Batalla Clavell J; Coll RP
    Rev Esp Salud Publica; 1999; 73(5):619-27. PubMed ID: 10650754
    [No Abstract]   [Full Text] [Related]  

  • 4. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination].
    Colomer Pache M; Arnedo Pena A
    Med Clin (Barc); 1988 Nov; 91(17):649-52. PubMed ID: 3230970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Strategies of measles eradication in the world].
    Olivé JM
    Rev Esp Salud Publica; 1999; 73(5):597-603. PubMed ID: 10650750
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complications of measles and antimeasles vaccination].
    Reinert P; Lemerle S; Kohout G; Bernaudin F
    Ann Pediatr (Paris); 1984 Jun; 31(6):477-80. PubMed ID: 6147112
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic indices of measles incidence in the years of mass inoculations with live measles vaccine].
    Shul'ga OE; Siniak KM
    Vrach Delo; 1979 May; (5):103-7. PubMed ID: 452582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Data on the evaluation of the epidemiologica and the immunologic effectiveness of the complex vaccine against measles and parotitis].
    Aksenova KI; Kozlova NA; Tregubova TV; Nasibov MN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():125-30. PubMed ID: 4808375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is it necessary to vaccinate against measles?].
    Celers J
    Arch Fr Pediatr; 1981 Nov; 38(9):651-2. PubMed ID: 7332428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reasons for vaccinating against measles].
    Celers J; Netter R
    Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV's challenge to measles control.
    Katz SL
    Clin Infect Dis; 2007 Dec; 45(11):1425-6. PubMed ID: 17990223
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and contraindications for the measles vaccination of children with an aggravated neurological anamnesis].
    Kossova ET; Dadiomova MA; Lakotkina EA; Ryzhova TP
    Tr Inst Im Pastera; 1979; 53():40-3. PubMed ID: 262710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up study on the effectiveness of measles vaccination].
    Vítková V; Sejda J
    Cesk Epidemiol Mikrobiol Imunol; 1972 Mar; 21(2):65-8. PubMed ID: 4260107
    [No Abstract]   [Full Text] [Related]  

  • 20. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.